S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
YK
INSIDER · RAPP · Rapport Therapeutics, Inc. · CHIEF DEVELOPMENT OFFICER

Yeleswaram Krishnaswamy

Every open-market transaction filed under this name, Aug 19 to Aug 25.

Filings
4
0 buys · 4 sells
Bought
open market, at cost
Sold
$2.6M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 25RAPPRapport Therapeutics, Inc.Chief Development OfficerSell16,201$51.06$827K−4.5%
Aug 25RAPPRapport Therapeutics, Inc.Chief Development OfficerSell20,799$50.31$1M−3.1%
Aug 24RAPPRapport Therapeutics, Inc.Chief Development OfficerSell13,160$50.00$658K−2.5%
Aug 19RAPPRapport Therapeutics, Inc.Chief Development OfficerSell404$49.90$20K−2.3%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.